Learn / NEO
NASDAQ: NEO
Neogenomics (NEO) stock, explained like you're 5
Neogenomics trades on the Nasdaq under the ticker NEO. It is a mid cap company in the precision instruments industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.
- Ticker
- NEO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Precision Instruments
- Size
- Mid cap, about 2.1 billion dollars
Is Neogenomics a small, medium or large cap company?
No. Neogenomics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Neogenomics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NEO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- NeoGenomics, Inc. (NEO) Stock Forecasts (Yahoo Finance)
- How Investors May Respond To NeoGenomics Stock AI Pathology Expansion (Simply Wall Street)
- A 4:30 p.m. ET webcast will cover NeoGenomics' third quarter results on Oct. 28. (Stock Titan)
- Why is NeoGenomics stock sliding today? (Investing.com)
- NeoGenomics stock fell 3.48 percent to USD 16.65 on October 16 (ad-hoc-news.de)
Follow NEO in your daily brief
Each trading day at 5 PM ET we post what happened to Neogenomics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NEO
Questions about Neogenomics stock
What does Neogenomics do?
Neogenomics trades on the Nasdaq under the ticker NEO. It is a mid cap company in the precision instruments industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.
What is the ticker symbol for Neogenomics?
Neogenomics trades under the ticker NEO on the Nasdaq.
What is Neogenomics's market cap?
Neogenomics is a mid cap stock with a market cap of about 2.1 billion dollars.
How does Neogenomics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NEO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NEO stock every day?
Add NEO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.